NA Advance Biotech Grant Program

The Advance Biotech Grant Program is offered on a regular basis in different regions of the world. The program recognizes stand-out emerging biopharmaceutical and biotech start-ups and awards grant recipients with products, services, and consultation to advance production and help accelerate the path to commercialization. Since 2014, more than 40 biotech startups have been recognized through this Program. We are honored to support their missions as they pursue therapeutic solutions for patients suffering from cancer, brain tumors, osteoarthritis, and cardiovascular disorders. To be considered for the grant, you must describe your therapeutic focus, clinical strategy, and explain how we can help you overcome challenges and address gaps in expertise to bring your innovation across the finish line. Winners receive product and service credits from Millipore Sigma.